A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2001
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1323629A Hyperosteogeny treating plaster
11/28/2001	CN1323614A Gufukang liniment for treating bone disease
11/28/2001	CN1323604A Foamed disease-treating ointment
11/28/2001	CN1323588A New use of ginseng and ginseng stalk and leaf extractive in preventing and treating osteoposis
11/28/2001	CN1075383C Bone-setting and muscle-jointing-up medicine and prepn. method thereof
11/28/2001	CN1075381C Medicine for treating hyperosteogeny and preparing method thereof
11/27/2001	US6323345 Process for Cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine
11/27/2001	US6323232 Combination therapy for osteoporosis
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087810A1 Methods for the production of d-chiro-inositol and the use of d-chiro-inositol obtained therefrom
11/22/2001	WO2001087343A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001	WO2001087294A1 Phosphate transport inhibitors
11/22/2001	WO2001087234A2 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/22/2001	WO2001046128A3 Tryptase inhibitors
11/22/2001	WO2001038355A3 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
11/22/2001	WO2001035995A3 Tr3-specific binding agents and methods for their use
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001030781A3 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
11/22/2001	WO2001018169A3 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
11/22/2001	US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine
11/22/2001	US20010044535 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044451 Tyrosine kinase inhibitors
11/22/2001	US20010044425 Therapeutically effective amount of ferrous ion and a therapeutically effective amount of an ascorbate
11/22/2001	DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001	DE10020667A1 Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln New benzoxazine and benzothiazine derivatives and their use in medicaments
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001	CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001	CA2409035A1 Hydroxamic acid derivatives
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408691A1 Compositions and methods for achieving immune suppression
11/22/2001	CA2408667A1 Phosphate transport inhibitors
11/22/2001	CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	CA2406013A1 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/22/2001	CA2348243A1 Herbal chinese joint complex
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156039A1 Pyridazin-3-one derivatives and medicines containing the same
11/21/2001	EP1156037A1 Chondrongenesis promotors and indolin-2-one derivatives
11/21/2001	EP1155304A2 A system for cell-based screening
11/21/2001	EP1155014A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
11/21/2001	EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001	EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP1154734A1 Injectable collagen-based system for delivery of cells or therapeutic agents
11/21/2001	EP0998292B1 Method for inhibiting bone resorption
11/21/2001	EP0958277B1 Nitric oxide synthase inhibitors
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001	EP0650480B1 1-arylsulphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/21/2001	EP0536186B1 Bone and cartilage inductive proteins
11/21/2001	CN1323314A Inhibitors of caspases
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1323211A New pharmaceutical uses for NOS inhibitors
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323206A Fumaric acid microtablets
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1323201A Extended release buccal bioadhesive tablet
11/21/2001	CN1323198A Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
11/21/2001	CN1322565A Fracture setting pellet
11/21/2001	CN1322564A Red wound plaster for treating bone fracture
11/21/2001	CN1322562A Chinese medicine plaster for treating hyperosteogeny and its preparation
11/21/2001	CN1322556A Chinese medicine preparation for treating rheumatism and rheumatoid disease
11/21/2001	CN1322555A Ointment for treating protrusion of lumber intervertebral disc and its preparation
11/21/2001	CN1322553A Medicine for treating hyperosteogeny and protrusion of lumber intervertebral disc and its preparation
11/21/2001	CN1322546A Fracture setting ointment with the function of promoting bone healing
11/21/2001	CN1322545A Fracture setting ointment with the function of promoting bone growth

1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 820